Cost-Effectiveness Analysis of the mRNA-1345 RSV Vaccine for Older Adults in Italy
Mariia Dronova, Camille Moyon, Lukasz Pyrek, Katherine A. Hicks et autres
fr, pl, us, it (code pays fourni par la source)
0 citations
medRxiv
Mariia Dronova
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
13Publications signalées
33Citations signalées
2Affiliations récentes
Les institutions déclarées
Les domaines associés
Respiratory viral infections researchInfluenza Virus Research StudiesVaccine Coverage and HesitancySARS-CoV-2 and COVID-19 ResearchHealth Systems, Economic Evaluations, Quality of Life
Les publications récentes
High/low temperature setups for submillimetric samples under various extreme conditions at the AILES beamline
Cecilia Taverna, Kelly Rader, Jean Blaise Brubach, Alexander Voute et autres
fr (code pays fourni par la source)
1 citation
Journal of Synchrotron Radiation
The Potential Public Health Impact of the mRNA-Based Respiratory Syncytial Virus Vaccine, mRNA-1345, Under Extended Vaccination Campaigns Among Older Adults in the United Kingdom: A Modelling Study
Mariia Dronova, Anna Tytuła, Zuzanna Janusz, Parinaz Ghaswalla et autres
fr, pl, us, gb (code pays fourni par la source)
0 citations
Vaccines
The Potential Public Health Impact of the mRNA-based Respiratory Syncytial Virus Vaccine, mRNA-1345, Under Extended Vaccination Campaigns Among Older Adults in the United Kingdom: A Modelling Study
Mariia Dronova, Anna Tytula, Zuzanna Janusz, Parinaz Ghaswalla et autres
us (code pays fourni par la source)
0 citations
medRxiv
Cost-Effectiveness Analysis of Influenza Treatments in Japan Using a Transmission Model: The Impact of Baloxavir and Oseltamivir Shares
Ataru Igarashi, Takahiro Takazono, Naoki Hosogaya, Naoya Itsumura et autres
jp, fr, pl (code pays fourni par la source)
2 citations
Infectious Diseases and Therapy
EE133 The Potential Impact of COVID-19 Vaccine Efficacy and Vaccination Coverage on Health Equity Among United States (US) Older Adults
Keya Joshi, Mariia Dronova, Ewelina Paterak, Justyna Sambor et autres
us, pl (code pays fourni par la source)
0 citations
Value in Health
Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States
Keya Joshi, Mariia Dronova, Ewelina Paterak, Văn Hùng Nguyễn et autres
us, pl, ie (code pays fourni par la source)
5 citations
Infectious Diseases and Therapy
EPH30 Assessing the Potential Public Health Impact of the mRNA-Based Respiratory Syncytial Virus (RSV) Vaccine, mRNA-1345, With a Broad Vaccination Campaign Among Older Adults in the United Kingdom: Modelling Study
Mariia Dronova, A Tytuła, Zuzanna Janusz, P Ghaswalla et autres
pl, us, gb (code pays fourni par la source)
0 citations
Value in Health
Clinical impact and cost-effectiveness of updated 2023/24 COVID-19 mRNA vaccination in high-risk populations in the United States
Keya Joshi, Mariia Dronova, Ewelina Paterak, Văn Hùng Nguyễn et autres
us, pl, ca (code pays fourni par la source)
3 citations
medRxiv
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics—Practical Considerations for Expanding Valuation by Including Key Concepts
Eliana Biundo, Mariia Dronova, A Chicoye, Richard Cookson et autres
be, fr, gb, au, es, us, nl, id, de (code pays fourni par la source)
7 citations
Vaccines
1152. Quantifying the health equity related public health impact of national immunisation programmes
Eliana Biundo, Mariia Dronova, A Chicoye, Richard Cookson et autres
be, gb, au, es, us, nl, de (code pays fourni par la source)
0 citations
Open Forum Infectious Diseases
Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan
Mariia Dronova, Hidetoshi Ikeoka, Naoya Itsumura, Nobuo Hirotsu et autres
jp (code pays fourni par la source)
15 citations
Current Medical Research and Opinion
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.